Drug Profile
Aristeromycin
Alternative Names: U 99468Latest Information Update: 08 Mar 2001
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Antivirals
- Mechanism of Action Adenosylhomocysteinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 08 Mar 2001 Discontinued-Preclinical for Cancer in USA (Unknown route)
- 08 Sep 1998 Profile reviewed
- 08 Sep 1998 No-Development-Reported for Cancer in USA (Unknown route)